Bio-Techne Corp. TECH recently launched an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

Bio-Techne, a global leader in life science tools and reagents, announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research ...

Bio-Techne (TECH) announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

MINNEAPOLIS, Feb. 20, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ in ...

In this webinar we will provide an overview of RNAscope™ ISH technology, then discuss our new RNAscope multiomic applications coming soon. RNAscope is the gold standard for RNA ISH -providing ...

Exaggerated immune responses contribute to COVID-19 pathogenesis. However, the specific cellular mediators and inflammatory components driving diverse clinical disease outcomes remain poorly ...

Bio-Techne Corporation, a global life sciences company, announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a ...

The latest RNAscope HiPlex12 Flex Kit enables researchers to visualise multiplexed RNA biomarkers using the Hyperion XTi. Credit: CDC on Unsplash. Bio-Techne has launched a new RNAscope multiomic ...

Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities announced the expansion of the Advanced Cell ...

Bio-Techne has launched the RNAscope Plus smRNA-RNA detection assay. It enables the simultaneous fluorescent detection of a small regulatory RNA and three target RNAs or RNA biomarkers in the same ...

An integrated assay using proprietary RNAscope™ and miRNAscope™ technologies to measure the biodistribution and function of novel gene therapies and endogenous regulatory RNAs. MINNEAPOLIS, Jan. 10, ...

Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of its Advanced Cell Diagnostics (ACD)-branded RNAscope™ in situ hybridization (ISH) portfolio with the release of the RNAscope Plus ...